S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Global Blood TherapeuticsRocket PharmaceuticalsOPKO HealthTaro Pharmaceutical IndustriesALX Oncology
SymbolNASDAQ:GBTNASDAQ:RCKTNASDAQ:OPKNYSE:TARONASDAQ:ALXO
Price Information
Current Price$44.48$55.74$4.70$72.91$87.68
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.61.61.91.11.9
Analysis Score4.42.53.52.51.5
Community Score3.02.92.52.23.8
Dividend Score0.00.00.00.00.0
Ownership Score0.02.51.70.03.3
Earnings & Valuation Score0.60.01.90.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$93.82$57.89$9.00$81.00$89.60
% Upside from Price Target110.93% upside3.86% upside91.49% upside11.10% upside2.19% upside
Trade Information
Market Cap$2.75 billion$3.08 billion$3.15 billion$2.79 billion$3.25 billion
Beta1.392.051.980.92N/A
Average Volume1,104,273472,0638,628,94430,079193,000
Sales & Book Value
Annual Revenue$2.11 millionN/A$901.90 million$644.77 millionN/A
Price / Sales1,302.69N/A3.494.33N/A
CashflowN/AN/AN/A$6.57 per shareN/A
Price / CashN/AN/AN/A11.09N/A
Book Value$9.61 per share$6.10 per share$2.43 per share$55.15 per shareN/A
Price / Book4.63N/A1.931.32N/A
Profitability
Net Income$-266,770,000.00$-77,270,000.00$-314,920,000.00$244.24 millionN/A
EPS($4.71)($1.58)($0.41)$6.35N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/A78.3317.40N/A
P/E GrowthN/AN/A5.84N/AN/A
Net Margins-332.94%N/A-9.79%-45.94%N/A
Return on Equity (ROE)-56.43%-35.81%-2.61%10.36%N/A
Return on Assets (ROA)-39.32%-27.52%-1.80%8.38%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.16%0.25%0.13%N/AN/A
Current Ratio7.63%7.30%1.27%2.53%N/A
Quick Ratio7.20%7.30%0.94%2.25%N/A
Ownership Information
Institutional Ownership PercentageN/AN/A28.51%11.23%73.45%
Insider Ownership Percentage4.30%41.40%40.90%13.80%N/A
Miscellaneous
Employees352846,0961,46417
Shares Outstanding61.80 million55.23 million670.04 million38.26 million37.11 million
Next Earnings Date5/5/2021 (Estimated)5/5/2021 (Estimated)5/5/2021 (Estimated)5/18/2021 (Estimated)3/4/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.